SEC Tracker
Get the app

Royalty Pharma RPRX

Marshall Urist (Officer) received 5,341 RPRX

Form
4
Filed
Importance
Routine
  1. Marshall Urist acquired 5,341 Class A Ordinary Shares on Nov 4, 2026.
  2. Marshall Urist acquired 150,000 Class A Ordinary Shares on Nov 6, 2026 through Sandy Lamm LLC.
  3. Marshall Urist holds 15,000 LP interests in RPI US Partners 2019, LP.

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Royalty Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
  2. Biogen BIIB public float $18.4B, Jun 30, 2025
  3. BeOne Medicines ONC public float $14.7B, Jun 30, 2025
  4. INSMED INSM public float $21.1B, Jun 30, 2025
  5. United Therapeutics UTHR public float $11.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.